Original language | English |
---|---|
Pages (from-to) | 152-160 |
Number of pages | 9 |
Journal | Journal of Infection |
Volume | 85 |
Issue number | 2 |
Early online date | 3 Jun 2022 |
DOIs | |
Publication status | Published - Aug 2022 |
Bibliographical note
Funding:This work is supported by grants from: the National Institute for Health Research (NIHR) [award COsingle bondCIN-01], the Medical Research Council [grant MC_PC_19059] and by the NIHR Health Protection Research Unit (HPRU) in Emerging and Zoonotic Infections at University of Liverpool in partnership with UK Health Security Agency (UKHSA), in collaboration with Liverpool School of Tropical Medicine and the University of Oxford [award 200907], NIHR HPRU in Respiratory Infections at Imperial College London with UKHSA [award 200927], NIHR Biomedical Research Centre at Imperial College London [IS-BRC-1215-20013], and NIHR Clinical Research Network for providing infrastructure support for this research. The views expressed are those of the authors and not necessarily those of the NIHR, MRC or UKHSA.
Funding was also available from UKRI CV220-11: Serological detection of past SARS-CoV-2 infection by non-invasive sampling for field epidemiology and quantitative antibody detection; held at Imperial College London.
Work in PC's laboratory was supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001061), the Wellcome Trust (FC001061), and the UK Medical Research Council (FC001061).
The funder had no role in the design and conduct of the study; collection, management, analysis and interpretation of the data; preparation, review or approval of the manuscript; and decision to submit the manuscript for publication
Study registration ISRCTN66726260
The ISARIC WHO CCP-UK study was registered at https://www.isrctn.com/ISRCTN66726260 and designated an Urgent Public Health Research Study by NIHR.